Bright Minds Biosciences Inc. closed fiscal year 2024 with $4.5M in total assets, $421K in total liabilities and $4.1M in shareholder equity. Total assets fell 11.1% from the prior fiscal year. The table below carries 5 fiscal years, from 2020 to 2024, and the quarters Bright Minds Biosciences Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
DRUG Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
DRUG Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Bright Minds Biosciences Inc. financials
Frequently Asked Questions
What was Bright Minds Biosciences Inc.'s total assets in fiscal year 2024?
Bright Minds Biosciences Inc. closed fiscal year 2024 with $4.5M in total assets, $421K in total liabilities and $4.1M in shareholder equity.
How fast is Bright Minds Biosciences Inc.'s total assets growing?
Bright Minds Biosciences Inc. (DRUG) total assets fell by 11.1% year over year, from $5.1M to $4.5M in fiscal year 2024.
How has Bright Minds Biosciences Inc.'s total assets changed over the years?
Across the 5 fiscal years this page covers, Bright Minds Biosciences Inc. (DRUG) total assets went from $661K in fiscal year 2020 to $4.5M in fiscal year 2024.
What was Bright Minds Biosciences Inc.'s total assets in the most recent quarter?
Bright Minds Biosciences Inc. (DRUG) reported $4.5M in total assets in Q4 2024. This represents a decrease of 11.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Bright Minds Biosciences Inc. (DRUG) reported on that line in every period on record.